On Wednesday, the University of Colorado Denver Business School and the Jake Jabs Center for Entrepreneurship celebrated the grand opening of the new Jake Jabs Event Center, Innovation Suite, and classrooms. Spanning the first three floors of the 1475 Lawrence Street building, these new spaces will help accommodate the growing demand for entrepreneurial and collaborative programming, events, and extracurriculars on the CU Denver campus. Read more
Although she didn’t present, Karissa Rund left this year’s Pitch Night as a winner.
At the final event for THE CLIMB, a collegiate business plan competition put on by CU Denver’s Jake Jabs for Entrepreneurship, Karissa took home the Social Impact Award for 8 Percent. Her idea wasn’t a product or service though, like those pitched by the other finalists. Instead, it laid out her plan to launch her own book and speaking tour. Read more
Whitney Setterberg and Peter Boardman, both students in the CU Denver Business School Professional MBA program, won the 2019 CLIMB Business Plan Competition on April 25 when they pitched their peer-to-peer storage service called STOWED. THE CLIMB, an annual event put on by Jake Jabs Center for Entrepreneurship, is designed to help student entrepreneurs transform their ideas into viable businesses through education, mentorship, networking, and financial support. Read more
DENVER (April 26, 2019) – More than 180 attendees packed the Curtis Hotel’s Four Square Ballroom on Thursday to watch aspiring collegiate entrepreneurs compete for cash prizes. Hosted by the Jake Jabs Center for Entrepreneurship at the University of Colorado Denver (CU Denver) Business School, THE CLIMB | Pitch Night showcased six finalists and their business ideas as they presented to a live panel of judges. Read more
Featuring John Carreyrou, two-time Pulitzer Prize-winning investigative reporter at The Wall Street Journal and author of the National Bestseller Bad Blood: Secrets and Lies in a Silicon Valley Startup.
Join us for the full inside story of the breathtaking rise and shocking collapse of Theranos, the multibillion-dollar biotech startup, by the prize-winning journalist who first broke the story and pursued it to the end, despite pressure from Theranos’ charismatic CEO and threats by her lawyers. Read more